S. Sato et al. / Tetrahedron 61 (2005) 11449–11455
11453
7.84 (s, 1H), 8.52 (s, 2H), 9.10 (s, 1H); 13C NMR (100 MHz,
CDCl3) d 52.90 (CH3!2), 128.31 (CH), 128.80 (CH),
129.62 (CH), 130.91 (CH), 131.13, 131.45 (CH), 132.73,
133.45, 135.76, 138.04, 144.20, 156.75 (CH), 157.40 (CH),
167.03, 167.42. Anal. Calcd for C20H16N2O4: C, 68.96; H,
4.63; N, 8.04. Found: C, 69.23; H, 4.75; N, 7.92.
(CH), 127.24 (CH), 128.04 (CH), 128.35 (CH), 129.01
(CH), 129.57 (CH), 130.37 (CH), 130.56, 132.13, 136.02,
139.06, 142.80, 158.29, 166.31, 168.80. The coupling
constant of two protons on benzene ring measured JZ
1.8 Hz, which indicate their meta-relationship.
4.3.9. 6-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-
biphenyl-3,4-dicarboxylic acid dimethyl ester 10.
CPDA 2a (358 mg, 1.00 mmol), ethynylboronate ester
(304 mg, 2.00 mmol), and dodecane (113 mL, 0.500 mmol,
internal standard) were dissolved in 0.50 mL of chloro-
benzene and heated at 120 8C. Complete consumption of
alkyne was confirmed after 42 h by GC analysis. The
solvent was removed in vacuo to give crude materials.
Purification by silica gel column chromatography (eluent:
3% ethyl acetate/toluene) afforded the title compound 10 as
a viscous liquid in 68% yield (269 mg, 0.679 mmol). IR
(liquid) 2979, 2952, 2111, 2092, 1727, 1546, 1509, 1486,
1436, 1389, 1324, 1285, 1247, 1131, 1096, 1067, 1028, 963,
4.3.7. 6-Cyclohex-1-enyl-biphenyl-3,4-dicarboxylic acid
dimethyl ester 7. CPDA 2a (179 mg, 0.500 mmol) and
1-ethynylcyclohexene (2.06 mL, 17.5 mmol) were dis-
solved in 0.95 mL of t-butanol and heated at 150 8C for
21 h in a sealed tube. The solvent was removed in vacuo to
give crude materials. Purification by silica gel column
chromatography (eluent: 15% ethyl acetate/hexane)
afforded the title compound 7 as a white solid in 75%
yield (131 mg, 0.375 mmol). IR (KBr) 3445, 2931, 1730,
1436, 1308, 1246, 1130, 1075, 968, 910, 772, 701 cmK1; 1H
NMR (500 MHz, CDCl3) d 1.43–1.48 (m, 2H), 1.49–1.54
(m, 2H), 1.75–1.79 (m, 2H), 2.07–2.12 (m, 2H), 3.90 (s,
3H), 3.93 (s, 3H), 5.75 (m, 1H), 7.32–7.43 (m, 5H), 7.59 (s,
1H), 7.67 (s, 1H); 13C NMR (75 MHz, CDCl3) d 21.70
(CH2), 22.67 (CH2), 25.59 (CH2), 28.76 (CH2), 52.56
(CH2), 52.60 (CH2), 127.56 (CH), 128.12 (CH), 128.62
(CH), 129.29 (CH), 129.83, 129.97 (CH), 130.57, 130.70
(CH), 138.05, 140.21, 142.43, 146.49, 167.85, 168.14. Anal.
Calcd for C22H22O4: C, 75.41; H, 6.33. Found: C, 75.28; H,
6.37.
1
895, 853, 828, 768, 739, 702, 689, 668 cmK1; H NMR
(500 MHz, CDCl3) d 1.21 (s, 12H), 3.91 (s, 3H), 3.92 (s,
3H), 7.38 (m, 5H), 7.68 (s, 1H), 8.08 (s, 1H); 13C NMR
(100 MHz, CDCl3) d 24.56 (CH3), 52.59 (CH3), 52.70
(CH3), 84.29, 127.81 (CH), 128.00 (CH), 128.87, 128.93
(CH), 129.05 (CH), 132.69 (br, CB), 133.54, 135.16 (CH),
141.18, 150.58, 167.85, 168.21. Anal. Calcd for
C22H25O6B: C, 66.69; H, 6.36. Found: C, 66.44; H, 6.50.
3
We observed JCH HMBC correlations between methyne
protons and carbonyl carbons and determined the positions
of substituents as shown in Table 2.
4.3.8. 6-Phenoxymethyl-biphenyl-3,4-dicarboxylic acid
dimethyl ester 8. CPDA 2a (17.9 mg, 50.0 mmol) and
phenylprop-2-yl ether (15.4 mL, 120 mmol) were dissolved
in 0.30 mL of 1,2,4-trichlorobenzene and stirred at 150 8C
for 8 days. Purification by silica gel column chromato-
graphy (eluent: 20% ethyl acetate/hexane) afforded the 5:1
mixture of regioisomers 8 and 9 in 91% yield (17.2 mg,
45.7 mmol). Anal. Calcd for C23H20O5: C, 73.39; H, 5.36.
Found: C, 73.28; H, 5.51. Purification by gel permeation
column chromatography afforded the title compound 8 as a
viscous liquid in 76% yield (14.3 mg, 38.0 mmol) and minor
product 9 as a viscous liquid in 15% yield (2.8 mg,
7.4 mmol).
4.3.10. 3,4,5-Triphenylphthalic acid dimethyl ester 11.15
CPDA 2a (17.9 mg, 50.0 mmol) and diphenylacetylene
(17.8 mg, 100 mmol) were dissolved in 0.10 mL of diphenyl
ether and refluxed for 12 h. Purification by silica gel column
chromatography (eluent: 5% ethyl acetate/toluene) afforded
the title compound 11 as a white solid in 39% yield (8.2 mg,
19 mmol). IR (powder) 3053, 3026, 2948, 1733, 1723, 1588,
1555, 1497, 1445, 1426, 1337, 1297, 1262, 1235, 1202,
1146, 1073, 1063, 1030, 965, 911, 849, 807, 766, 753,
700 cmK1; 1H NMR (400 MHz, CDCl3) d 3.56 (s, 3H), 3.92
(s, 3H), 6.76 (m, 2H), 6.93 (m, 3H), 7.06 (m, 4H), 7.12 (m,
3H), 7.16 (m, 3H), 8.11 (s, 1H); 13C NMR (100 MHz,
CDCl3) d 52.15 (CH3), 52.58 (CH3), 126.13, 126.40 (CH),
126.89 (CH), 127.01 (CH), 127.15 (CH), 127.23 (CH),
127.76 (CH), 129.64 (CH), 130.19 (CH), 130.82 (CH),
131.02 (CH), 135.15, 137.59, 138.07, 140.29, 140.31,
142.76, 144.78, 165.88, 169.10. Anal. Calcd for
C22H18O4: C, 79.60; H, 5.25. Found: C, 79.50; H, 5.47.
Compound 8. IR (KBr) 3059, 3029, 2951, 1730, 1599, 1587,
1496, 1435, 1393, 1313, 1242, 1193, 1170, 1133, 1072,
1
1031, 966, 912, 848, 793, 756, 704, 692 cmK1; H NMR
(400 MHz, CDCl3) d 3.91 (s, 3H), 3.93 (s, 3H), 4.96 (s, 2H),
6.85 (m, 2H), 6.94 (m, 1H), 7.25 (m, 2H), 7.34–7.45 (m,
5H), 7.68 (s, 1H), 8.06 (s, 1H); 13C NMR (100 MHz,
CDCl3) d 52.68 (CH3!2), 67.06 (CH2), 114.78 (CH),
121.27 (CH), 128.23 (CH), 128.56 (CH), 128.76 (CH),
129.46 (CH), 129.48 (CH), 130.51, 130.78, 131.40 (CH),
137.68, 138.42, 144.28, 158.15, 167.67, 167.78. We
4.3.11. Diels–Alder adduct of CPDA and 2,5-norborna-
diene 12.6 CPDA 2a (143 mg, 0.400 mmol) was dissolved
in 0.80 mL of 2,5-norbornadiene and stirred at 80 8C for 7 h,
and the solvent was removed in vacuo to give the title
compound 12 as a white solid in 98% yield (176 mg,
0.392 mmol). A single crystal was obtained by recrystalliza-
tion from methylene chloride/pentane, and the structure was
determined by X-ray diffraction study. IR (powder) 2962,
2946, 1740, 1717, 1600, 1465, 1447, 1434, 1362, 1312,
1299, 1275, 1264, 1250, 1233, 1221, 1210, 1191, 1177,
1158, 1127, 1113, 1094, 1073, 1059, 1032, 1003, 974, 965,
942, 924, 909, 895, 868, 853, 814, 801, 785, 770, 747, 720,
3
observed JCH HMBC correlations between methyne
protons and carbonyl carbons and determined the positions
of substituents as shown in Table 2.
Compound 9. IR (KBr) 2951, 2919, 2858, 1730, 1599, 1496,
1456, 1434, 1382, 1331, 1242, 1159, 1107, 1068, 1033, 986,
755, 693 cmK1; 1H NMR (400 MHz, CDCl3) d 3.92 (s, 3H),
3.94 (s, 3H), 5.19 (s, 2H), 6.97 (m, 3H), 7.29 (m, 2H), 7.41
(m, 1H), 7.47 (m, 2H), 7.60 (s, 2H), 7.97 (m, 1H), 8.14
(d, JZ1.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) d 52.69
(CH3), 52.77 (CH3), 67.13 (CH2), 114.84 (CH), 121.39
1
702, 687, 656, 621 cmK1; H NMR (500 MHz, CDCl3) d